Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
PREDICTOM Highlights the Power of Partnership and Public Involvement at Alzheimer Europe Conference 2026
At the 36th Alzheimer Europe Conference in Dublin, the PREDICTOM sponsored session opened with a video message from Dr. Niklas Blomberg, Executive Director of the Innovative Health Initiative (IHI). His remarks placed PREDICTOM within the broader mission of IHI and underscored two key ingredients for successful health innovation: meaningful patient and public involvement, and strong partnerships across sectors.
News
AI-Powered Screening Tool Helps Identify People at Higher Risk of Dementia
An innovative AI-powered screening gatekeeper could help transform how dementia risk is assessed. Researchers from the European PREDICTOM project have developed a risk stratification pipeline that combines established risk factors and cognitive performance data to identify people most likely to benefit from further investigation, helping target costly tests where they are needed most.
News
Home-Based Alzheimer's Blood Testing Shows Promise, but Collecting Quality Samples Remains a Challenge
Could older adults one day participate in Alzheimer's screening without leaving home? Researchers behind the European PREDICTOM project are exploring that possibility through remote blood collection, but new findings suggest that the biggest hurdle may be getting a good blood sample in the first place.
PREDICTOM Study Progress
This page provides regularly updated information on the progress of the PREDICTOM study for everyone interested in following its development. The tracker will show progress for both Level 1 and Level 2 as the study advances.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.